* * *
Please support I. U.
Healthy TRIPLETS all become severely autistic within hours of vaccination… see shocking video that has the vaccine industry doubling down on lies and disinfohttps://t.co/O8Tghbpt0r#Health #Vaccination #Vaccines #BreakingNews #Breaking #Autism #Parenting #Babies #Baby
— Infinite Unknown (@SecretNews) December 24, 2018
* * *
With just a single dose of this 100-year-old drug, autistic children experienced remarkable positive cognitive and emotional improvements. Some of the children spoke their first sentences in more than a decade. This is truly a ‘game changer.’
According to a revolutionary new study, a drug discovered more than a century ago may hold the key to combating the symptoms of autism. After just one dose, parents of the children in the study watched their kids make incredible improvements, with some speaking for the first time.
The study’s lead researcher, Dr. Robert Naviaux of the San Diego School of Medicine is an internationally known expert in human genetics, inborn errors of metabolism, metabolomics, and mitochondrial medicine. He is the discoverer of the cause of Alpers syndrome — the oldest Mendelian form of mitochondrial disease — and the developer of the first DNA test to diagnose it. Naviaux is, by far, one of the most qualified people in the world to conduct this study.
During his research, Naviaux noted the transformative results of the drug suramin which was first developed in 1916 and used as an anti-parasitic drug for treating African sleeping sickness and river blindness. After giving a single dose of suramin to boys with autism, between the ages of five and 14, Naviaux recorded something incredible — their symptoms were significantly alleviated.
“After the single dose, it was almost like a roadblock had been released,” he said. “If the future studies show that there’s continued health benefits, this could be a game-changer for families with autism.”
The study was published in the Annals of Clinical and Translational Neurology. During the study, five children were given suramin, while the remainder were given placebos. Included in the group were four non-verbal children, two 6-year-olds, and two 14-year-olds.
As some people continue to deny that there is a link between autism spectrum disorder and mercury, a pair of new studies have now been added to the growing pile of evidence illustrating just how wrong they are.
The research involved meta-analysis of studies investigating the link between mercury and autism spectrum disorder that were carried out over the past 12 years. This type of study is highly advantageous as it allows researchers to consolidate vast piles of research, which can often be complex and even conflicting.
The first meta-analysis, which was carried out by researchers from the Shahrekord University of Medical Sciences in Iran, was focused specifically on mercury. The second one, which was conducted by Tehran University of Medical Sciences researchers, looked at mercury as well as other heavy metals like lead. In both cases, cutting-edge statistical techniques were used to yield unbiased results.
It’s a well-known fact that even the smallest amount of aluminum, if found in a person’s brain tissue, can become a huge problem. There have also been many studies that look into how having high-levels of aluminum in brain tissue is correlated with neurological conditions such as Alzheimer’s disease. Now a new study puts the spotlight on autism spectrum disorder (ASD), and tests to see if there might be a connection between it and having high-levels of aluminum in the brain.
The study, which was first published in the Journal of Trace Elements in Medicine and Biology, shows some of the highest levels of aluminum ever recorded in human brain tissue. The data was gathered from the brains of 10 donors who had ASD. The study was lead by Dr. Christopher Exley, one of the world’s leading experts on aluminum toxicity, from Keele University.